These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8860970)

  • 21. Urine volume as a predicting factor for furosemide clearance during continuous infusion in AKI septic shock patients on hemodiafiltration.
    Mariano F; Leporati M; Carignano P; Stella M; Vincenti M; Biancone L
    J Nephrol; 2018 Dec; 31(6):889-897. PubMed ID: 30225802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of furosemide in plasma and urine using monolithic silica rod liquid chromatography.
    Wenk M; Haegeli L; Brunner H; Krähenbühl S
    J Pharm Biomed Anal; 2006 Jun; 41(4):1367-70. PubMed ID: 16569489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and diuretic effect of furosemide after single intravenous, oral tablet, and newly developed oral disintegrating film administration in healthy beagle dogs.
    Koh SK; Jeong JW; Choi SI; Kim RM; Koo TS; Cho KH; Seo KW
    BMC Vet Res; 2021 Sep; 17(1):295. PubMed ID: 34488750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A bioequivalence study of two products of furosemide tablets.
    Awad R; Arafat T; Saket M; Saleh M; Gharaibeh M; Zmeili S; Sallam E; Shubair M; Qobrosi S
    Int J Clin Pharmacol Ther Toxicol; 1992 Jan; 30(1):18-23. PubMed ID: 1551740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioequivalence evaluation of two brands of furosemide 40 mg tablets (Salurin and Lasix) in healthy human volunteers.
    Najib N; Idkaidek N; Beshtawi M; Bader M; Admour I; Alam SM; Zaman Q; Dham R
    Biopharm Drug Dispos; 2003 Sep; 24(6):245-9. PubMed ID: 12973821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of ascorbic acid enhancement of the bioavailability and diuretic effect of furosemide.
    Lee MG; Chiou WL
    Drug Metab Dispos; 1998 May; 26(5):401-7. PubMed ID: 9571221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers.
    Klausner EA; Lavy E; Stepensky D; Cserepes E; Barta M; Friedman M; Hoffman A
    J Clin Pharmacol; 2003 Jul; 43(7):711-20. PubMed ID: 12856384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Input rate as a major determinant of furosemide pharmacodynamics: influence of fluid replacement and hypoalbuminemia.
    Castañeda-Hernández G; Vergés J; Pichette V; Héroux L; Caillé G; du Souich P
    Drug Metab Dispos; 2000 Mar; 28(3):323-8. PubMed ID: 10681377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of tablet dissolution on furosemide bioavailability: a bioequivalence study.
    McNamara PJ; Foster TS; Digenis GA; Patel RB; Craig WA; Welling PG; Rapaka RS; Prasad VK; Shah VP
    Pharm Res; 1987 Apr; 4(2):150-3. PubMed ID: 3509139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of furosemide administered 4 and 24 hours prior to high-speed exercise in horses.
    Knych HK; Vale A; Wilson WD; Kass PH; Arthur RM; Jones JH
    J Vet Pharmacol Ther; 2018 Apr; 41(2):224-229. PubMed ID: 29057472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of pharmaceutical quality of furosemide tablets from multinational markets.
    Qureshi SA; McGilveray IJ
    Drug Dev Ind Pharm; 1998 Nov; 24(11):995-1005. PubMed ID: 9876554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure.
    Gottlieb SS; Khatta M; Wentworth D; Roffman D; Fisher ML; Kramer WG
    Am J Med; 1998 Jun; 104(6):533-8. PubMed ID: 9674715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diuretic effect and disposition of furosemide in cystic fibrosis.
    Prandota J; Smith IJ; Hilman BC; Wilson JT
    Eur J Clin Pharmacol; 1991; 40(4):333-41. PubMed ID: 2050167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacokinetics and diuretic effect of furosemide in plain tablet and retard capsule with normal subjects and cirrhotic patients.
    Uchino K; Isozaki S; Amano J; Tanaka N; Saitoh Y; Nakagawa F; Tamura Z; Oka H
    J Pharmacobiodyn; 1983 Sep; 6(9):684-91. PubMed ID: 6655548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure.
    Cohen N; Golik A; Dishi V; Zaidenstein R; Weissgarten J; Averbukh Z; Modai D
    Miner Electrolyte Metab; 1996; 22(4):248-52. PubMed ID: 8807629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inclusion complexation of furosemide in cyclodextrins. Part 2: Implication on bioavailability.
    Ammar HO; Ghorab M; Emara LH; el-Nahhas SA; Makram TS
    Pharmazie; 1999 Mar; 54(3):207-10. PubMed ID: 10192107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of furosemide urinary elimination by nephrotic children.
    Prandota J
    Pediatr Res; 1983 Feb; 17(2):141-7. PubMed ID: 6828331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamic assessment of diuretic efficacy and braking in a furosemide continuous infusion model.
    Adin D; Atkins C; Papich MG
    J Vet Cardiol; 2018 Apr; 20(2):92-101. PubMed ID: 29483040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and evaluation of a monolithic floating dosage form for furosemide.
    Menon A; Ritschel WA; Sakr A
    J Pharm Sci; 1994 Feb; 83(2):239-45. PubMed ID: 8169797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.